secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K/A
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001601830-24-000224
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Recursion issues 102.3M shares to close Exscientia acquisition
--------------------------------------------------------------

- 102,298,808 shares of Class A common stock issuable to Exscientia shareholders and option/RSU holders.
- Shares issued in exchange for Exscientia ordinary shares and canceled equity awards under the Transaction Agreement.
- Issuance exempt from registration under Securities Act Section 3(a)(10).
- Transaction closed on November 20, 2024; this Amendment provides final share count.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/0001601830-24-000224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/rxrx-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer